Cemiplimab (Anti-Human PD-1) is a human monoclonal antibody that inhibits the PD-1/PD-L1 pathway, serving as a checkpoint inhibitor. It is applicable in research on metastatic cancer and squamous cell skin cancer.
Purity:
95.20%
CAS Number:
[1801342-60-8]
Target:
PD-1/PD-L1|||Others
* VAT and and shipping costs not included. Errors and price changes excepted